Company Filing History:
Years Active: 1991
Title: Bruce Schneider: Innovator in Muscle Treatment
Introduction
Bruce Schneider is a notable inventor based in Great Neck, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of skeletal muscle wasting and protein degradation.
Latest Patents
Schneider holds a patent for a method aimed at inhibiting wasting and protein degradation of mammalian muscle. This patent describes a method for treating mammals suffering from skeletal muscle wasting and/or intracellular protein degradation by administering tetracycline. The treatment results in a significant reduction of muscle wasting and protein degradation. Additionally, the patent outlines a method for increasing the protein content of skeletal muscle systems in mammals through the administration of tetracyclines, which can be either antimicrobial or non-antimicrobial. A preferred embodiment of this treatment utilizes a non-antimicrobial tetracycline, specifically dedimethylaminotetracycline (CMT). He has been granted 1 patent for this innovative approach.
Career Highlights
Bruce Schneider is affiliated with the State University of New York, where he continues to contribute to research and development in his field. His work has the potential to impact the treatment of conditions related to muscle degradation, offering new hope for affected individuals.
Collaborations
Throughout his career, Schneider has collaborated with notable colleagues, including Robert A Greenwald and Jonathan Maimon. These partnerships have likely enriched his research and expanded the scope of his innovations.
Conclusion
In summary, Bruce Schneider is a pioneering inventor whose work in muscle treatment showcases the potential of tetracycline in addressing significant health issues. His contributions are valuable to the medical community and hold promise for future advancements in treatment methodologies.